Carmen Ezpeleta

2.2k total citations · 1 hit paper
78 papers, 1.2k citations indexed

About

Carmen Ezpeleta is a scholar working on Epidemiology, Infectious Diseases and Modeling and Simulation. According to data from OpenAlex, Carmen Ezpeleta has authored 78 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Epidemiology, 28 papers in Infectious Diseases and 13 papers in Modeling and Simulation. Recurrent topics in Carmen Ezpeleta's work include Respiratory viral infections research (31 papers), Influenza Virus Research Studies (29 papers) and COVID-19 epidemiological studies (13 papers). Carmen Ezpeleta is often cited by papers focused on Respiratory viral infections research (31 papers), Influenza Virus Research Studies (29 papers) and COVID-19 epidemiological studies (13 papers). Carmen Ezpeleta collaborates with scholars based in Spain, United States and France. Carmen Ezpeleta's co-authors include Jesús Castilla, Iván Martínez‐Baz, Ana Navascués, Marcela Guevara, Itziar Casado, Manuel Garcìa Cenoz, Camino Trobajo‐Sanmartín, Aitziber Aguinaga, Cristina Burgui and Aurelio Barricarte and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Carmen Ezpeleta

75 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effectiveness of Nirsevimab Immunoprophylaxis Administered at Birth to Prevent Infant Hospitalisation for Respiratory Syncytial Virus Infection: A Population-Based Cohort Study

2024 43 citations Guillermo Ezpeleta, Ana Navascués et al. Vaccines profile →

Peers

Countries citing papers authored by Carmen Ezpeleta

Since Specialization

Citations

This map shows the geographic impact of Carmen Ezpeleta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Ezpeleta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Ezpeleta more than expected).

Fields of papers citing papers by Carmen Ezpeleta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen Ezpeleta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Ezpeleta. The network helps show where Carmen Ezpeleta may publish in the future.

Co-authorship network of co-authors of Carmen Ezpeleta

This figure shows the co-authorship network connecting the top 25 collaborators of Carmen Ezpeleta. A scholar is included among the top collaborators of Carmen Ezpeleta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen Ezpeleta. Carmen Ezpeleta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hospitalisation due to respiratory syncytial virus in a population-based cohort of older adults in Spain, 2016/17 to 2019/20 2025 ·Eurosurveillance ·(unknown), Camino Trobajo‐Sanmartín, Ana Navascués, (unknown), Itziar Casado, Carmen Ezpeleta, Jesús Castilla, Iván Martínez‐Baz	3
2	Effectiveness of Nirsevimab Immunoprophylaxis Administered at Birth to Prevent Infant Hospitalisation for Respiratory Syncytial Virus Infection: A Population-Based Cohort Study breakdown → 2024 ·Vaccines ·Guillermo Ezpeleta, Ana Navascués, (unknown), (unknown), S. Belloc, (unknown), Juan Carlos Muruzábal, Manuel Garcìa Cenoz, Camino Trobajo‐Sanmartín, (unknown), Iván Martínez‐Baz, (unknown), Itziar Casado, (unknown), Carmen Ezpeleta, Jesús Castilla	43
3	Hospitalisations and Deaths Averted by COVID-19 Vaccination in Navarre, Spain, 2021–2022 2024 ·Vaccines ·Iván Martínez‐Baz, Camino Trobajo‐Sanmartín, Ana Miqueleiz, Nerea Egüés, Manuel Garcìa Cenoz, Itziar Casado, Ana Navascués, Miguel Fernández-Huerta, (unknown), Marcela Guevara, Carmen Ezpeleta, Jesús Castilla	2
4	Prevalence of Respiratory Viral Infections in Deceased Persons during the COVID-19 Pandemic Season 2021–2022: A Population-Based Observational Study 2024 ·Viruses ·Camino Trobajo‐Sanmartín, Ana Navascués, Miguel Fernández-Huerta, Iván Martínez‐Baz, Itziar Casado, Carmen Ezpeleta, Jesús Castilla	1
5	Effectiveness of influenza vaccination in preventing confirmed influenza cases and hospitalizations in Northern Spain, 2023/24 season: A population-based test-negative case-control study 2024 ·International Journal of Infectious Diseases ·Iván Martínez‐Baz, Ana Navascués, Camino Trobajo‐Sanmartín, Francisco Pozo, Miguel Fernández-Huerta, (unknown), (unknown), Guillermo Ezpeleta, (unknown), Itziar Casado, Carmen Ezpeleta, Jesús Castilla	3
6	Evaluation of the use of sonication combined with enzymatic treatment for biofilm removal in the microbiological diagnosis of prosthetic joint infection 2024 ·Microbiology Spectrum ·(unknown), Carmen Alonso-Martín, Maite Echeverz, Íñigo Lasa, Carmen Ezpeleta, María Eugenia Portillo	0
7	Risk reduction of hospitalisation and severe disease in vaccinated COVID-19 cases during the SARS-CoV-2 variant Omicron BA.1-predominant period, Navarre, Spain, January to March 2022 2023 ·Eurosurveillance ·Iván Martínez‐Baz, Camino Trobajo‐Sanmartín, Ana Miqueleiz, Itziar Casado, Ana Navascués, Cristina Burgui, Carmen Ezpeleta, Jesús Castilla, Marcela Guevara, (unknown)	16
8	Influenza Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Cases and Hospitalizations in Navarre, Spain, 2022–2023 2023 ·Vaccines ·Iván Martínez‐Baz, Miguel Fernández-Huerta, Ana Navascués, Francisco Pozo, Camino Trobajo‐Sanmartín, Itziar Casado, (unknown), Carmen Ezpeleta, Jesús Castilla	6
9	Direct Prosthetic Joint Infection Diagnosis from Sonication Fluid Inoculated in Blood Culture Bottles by Direct MALDI-TOF Mass Spectrometry 2023 ·Diagnostics ·(unknown), (unknown), (unknown), (unknown), Angel Manuel Hidalgo Ovejero, Carmen Ezpeleta, María Eugenia Portillo	10
10	Seroprevalence of antibodies against SARS-CoV-2 and risk of COVID-19 in Navarre, Spain, May to July 2022 2022 ·Eurosurveillance ·Jesús Castilla, (unknown), (unknown), (unknown), Ana Miqueleiz, Camino Trobajo‐Sanmartín, Ana Navascués, Iván Martínez‐Baz, Itziar Casado, Cristina Burgui, Nerea Egüés, Guillermo Ezpeleta, Carmen Ezpeleta	15
11	Differences in Transmission between SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) Variants 2022 ·Microbiology Spectrum ·Camino Trobajo‐Sanmartín, Iván Martínez‐Baz, Ana Miqueleiz, Miguel Fernández-Huerta, Cristina Burgui, Itziar Casado, (unknown), Ana Navascués, Jesús Castilla, Carmen Ezpeleta	25
12	Effectiveness of influenza vaccination in preventing influenza in primary care, Navarre, Spain, 2021/22 2022 ·Eurosurveillance ·Iván Martínez‐Baz, Itziar Casado, Ana Miqueleiz, Ana Navascués, Francisco Pozo, Camino Trobajo‐Sanmartín, Esther Albéniz, (unknown), Cristina Burgui, Miguel Fernández-Huerta, Carmen Ezpeleta, Jesús Castilla	8
13	Comparison of the Risk of Hospitalization and Severe Disease Among Co-circulating Severe Acute Respiratory Syndrome Coronavirus 2 Variants 2022 ·The Journal of Infectious Diseases ·Camino Trobajo‐Sanmartín, Ana Miqueleiz, Marcela Guevara, Miguel Fernández-Huerta, Cristina Burgui, Itziar Casado, (unknown), Ana Navascués, Carmen Ezpeleta, Jesús Castilla	12
14	Viruses Previously Identified in Brazil as Belonging to HIV-1 CRF72_BF1 Represent Two Closely Related Circulating Recombinant Forms, One of Which, Designated CRF122_BF1, Is Also Circulating in Spain 2022 ·Frontiers in Microbiology ·J. Cañada, (unknown), Horacio Gil, (unknown), Mónica Sánchez, Antonio Ocampo, Jorge Julio Cabrera, Celia Miralles, (unknown), Ana Mariño, (unknown), (unknown), Carmen Ezpeleta, Michael M. Thomson	2
15	Product-specific COVID-19 vaccine effectiveness against secondary infection in close contacts, Navarre, Spain, April to August 2021 2021 ·Eurosurveillance ·Iván Martínez‐Baz, Camino Trobajo‐Sanmartín, Ana Miqueleiz, Marcela Guevara, Miguel Fernández-Huerta, Cristina Burgui, Itziar Casado, María Eugenia Portillo, Ana Navascués, Carmen Ezpeleta, Jesús Castilla, (unknown)	49
16	Self-Collection of Saliva Specimens as a Suitable Alternative to Nasopharyngeal Swabs for the Diagnosis of SARS-CoV-2 by RT-qPCR 2021 ·Journal of Clinical Medicine ·Camino Trobajo‐Sanmartín, (unknown), Ana Navascués, María Jesús Guembe, (unknown), Jesús Castilla, Carmen Ezpeleta	12
17	Hypertension and Related Comorbidities as Potential Risk Factors for COVID-19 Hospitalization and Severity: A Prospective Population-Based Cohort Study 2021 ·Journal of Clinical Medicine ·Ujué Fresán, Marcela Guevara, Camino Trobajo‐Sanmartín, Cristina Burgui, Carmen Ezpeleta, Jesús Castilla	17
18	Risk Factors of Infection, Hospitalization and Death from SARS-CoV-2: A Population-Based Cohort Study 2021 ·Journal of Clinical Medicine ·Jesús Castilla, Marcela Guevara, Ana Miqueleiz, (unknown), (unknown), Ana Navascués, Camino Trobajo‐Sanmartín, Iván Martínez‐Baz, Itziar Casado, Cristina Burgui, Carmen Ezpeleta, (unknown)	48
19	Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021 2021 ·Eurosurveillance ·Iván Martínez‐Baz, Ana Miqueleiz, Itziar Casado, Ana Navascués, Camino Trobajo‐Sanmartín, Cristina Burgui, Marcela Guevara, Carmen Ezpeleta, Jesús Castilla, (unknown)	56
20	Influenza Vaccination and Risk of SARS-CoV-2 Infection in a Cohort of Health Workers 2020 ·Vaccines ·Iván Martínez‐Baz, Camino Trobajo‐Sanmartín, (unknown), Ana Navascués, (unknown), (unknown), Ujué Fresán, Carmen Ezpeleta, Jesús Castilla	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact